ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Is Testosterone to Estradiol Ratio Important in Men?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 22418" data-attributes="member: 3"><p>CLINICAL UROLOGY: Original Articles</p><p></p><p><strong>EVIDENCE OF A TREATABLE ENDOCRINOPATHY IN INFERTILE MEN</strong></p><p>The Journal of Urology</p><p>Volume 165, Issue 3, March 2001, Pages 837–841</p><p></p><p>Purpose</p><p>We establish whether a subset of infertile men have decreased serum testosterone-to-estradiol ratios and whether this condition can be corrected with an oral aromatase inhibitor.</p><p></p><p>Materials and Methods</p><p></p><p>The serum testosterone-to-estradiol ratios of 63 men with severe male factor infertility or hypergonadotropic hypogonadism (mean follicle-stimulating hormone 21.2 ± 1.8) were compared with those of an age matched, fertile, control reference group. Of the 63 men 43 were azoospermic with biopsy proved severe male infertility and 20 were oligospermic. The men with the lowest ratios (less than 20th percentile) were treated with 50 to 100 mg. of the aromatase inhibitor testolactone orally twice daily. Testosterone-to-estradiol ratios and semen analyses were evaluated during testolactone therapy.</p><p></p><p>Results</p><p>Men with severe male infertility had significantly lower testosterone (328 versus 543 ng./dl., p <0.01) and higher estradiol (58.4 versus 43.5 ng./l., p = 0.01) than fertile control reference subjects, resulting in a decreased testosterone-to-estradiol ratio (×10[SUP]−1[/SUP] = 6.9 ± 0.6 versus 14.5 ± 1.2, respectively, p <0.01). Of the 45 men treated with testolactone a correction of these abnormalities was seen and ratios (×10[SUP]−1[/SUP]) increased into the normal range (5.0 ± 0.3 to 12.7 ± 1.2, p <0.01). Semen analyses were considered evaluable only in men with sperm in the ejaculate before aromatase inhibitor treatment. Semen analyses before and during testolactone treatment revealed significant increases in sperm concentration (16.1 to 28.9 million sperm per ml., p = 0.03) and motility (27.1% to 45.3%, p <0.01) in 12 oligospermic men.</p><p>[h=4]Conclusions[/b]We identified an endocrinopathy in men with severe male factor infertility that is characterized by a decreased serum testosterone-to-estradiol ratio. This ratio can be corrected by aromatase inhibition, resulting in a significant improvement in semen parameters in oligospermic patients.</p><p></p><p>T/E2 Ratios:</p><p></p><p>[ATTACH]1537[/ATTACH]</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 22418, member: 3"] CLINICAL UROLOGY: Original Articles [B]EVIDENCE OF A TREATABLE ENDOCRINOPATHY IN INFERTILE MEN[/B] The Journal of Urology Volume 165, Issue 3, March 2001, Pages 837–841 Purpose We establish whether a subset of infertile men have decreased serum testosterone-to-estradiol ratios and whether this condition can be corrected with an oral aromatase inhibitor. Materials and Methods The serum testosterone-to-estradiol ratios of 63 men with severe male factor infertility or hypergonadotropic hypogonadism (mean follicle-stimulating hormone 21.2 ± 1.8) were compared with those of an age matched, fertile, control reference group. Of the 63 men 43 were azoospermic with biopsy proved severe male infertility and 20 were oligospermic. The men with the lowest ratios (less than 20th percentile) were treated with 50 to 100 mg. of the aromatase inhibitor testolactone orally twice daily. Testosterone-to-estradiol ratios and semen analyses were evaluated during testolactone therapy. Results Men with severe male infertility had significantly lower testosterone (328 versus 543 ng./dl., p <0.01) and higher estradiol (58.4 versus 43.5 ng./l., p = 0.01) than fertile control reference subjects, resulting in a decreased testosterone-to-estradiol ratio (×10[SUP]−1[/SUP] = 6.9 ± 0.6 versus 14.5 ± 1.2, respectively, p <0.01). Of the 45 men treated with testolactone a correction of these abnormalities was seen and ratios (×10[SUP]−1[/SUP]) increased into the normal range (5.0 ± 0.3 to 12.7 ± 1.2, p <0.01). Semen analyses were considered evaluable only in men with sperm in the ejaculate before aromatase inhibitor treatment. Semen analyses before and during testolactone treatment revealed significant increases in sperm concentration (16.1 to 28.9 million sperm per ml., p = 0.03) and motility (27.1% to 45.3%, p <0.01) in 12 oligospermic men. [h=4]Conclusions[/b]We identified an endocrinopathy in men with severe male factor infertility that is characterized by a decreased serum testosterone-to-estradiol ratio. This ratio can be corrected by aromatase inhibition, resulting in a significant improvement in semen parameters in oligospermic patients. T/E2 Ratios: [ATTACH]1537[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Is Testosterone to Estradiol Ratio Important in Men?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top